Download Citation on ResearchGate | DERMATOMIOSITIS JUVENIL Y EMBARAZO | The juvenile dermatomyositis is a chronic inflammatory. Palabras clave: Dermatomiositis, debilidad muscular, miopatía. La dermatomiositis (DM) es una enfermedad que, junto . Tipo IV. Dermatomiositis juvenil. Summary. Epidemiology. The exact prevalence of JDM is not known. Estimated annual incidence rates range from 1/, to 1/, Females are affected .
|Genre:||Health and Food|
|Published (Last):||28 November 2015|
|PDF File Size:||18.86 Mb|
|ePub File Size:||2.3 Mb|
|Price:||Free* [*Free Regsitration Required]|
The aim of treatment is to reduce long-term morbidity and to restore physical function.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
Los investigadores creen que puede ser el resultado de una respuesta anormal del sistema inmune causado por un virus. Dermatomyositis occurring dermatomiosiyis the age of 18 years is considered to be JDM.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Juvenile dermatomyositis in a child infected with human parvovirus B Los inmunosupresores bajan el sistema inmune del cuerpo, aumentando el riesgo de coger infecciones. The aim of this study is to review the presenting signs and symptoms, laboratory findings and therapeutic regimens of juvenile dermatomyositis in a tertiary hospital.
Rheumatol23, 8, The Impact Factor measures the average number of citations received in a particular year by papers dermatoiositis in the journal during the two receding years. Macrophage activation syndrome, a severe sometimes life-threatening condition, has been described in some children diagnosed with JDM. Arch Dermatol,pp. CiteScore measures dermatomiosiyis citations received per document published.
Published studies are primarily clinical and epidemiological research but also basic. Continuing navigation will be considered as acceptance of this use. Munch Med Wochschr 34, Rermatomiositis Dis Child, 72pp.
Hospital 12 de Octubre. Prognosis Treatment is generally effective, with very low mortality rates reported. Este tratamiento se usa para las enfermedades de la piel activas o cuando se han probado otros medicamentos pero han fallado. Previous article Next article. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
Juvenile dermatomyositis JDM is an idiopathic inflammatory myopathy IMM of presumed autoimmune dysfunction resulting in muscle weakness among other complications. The UK incidence is deramtomiositis to be between per million children per year, with some difference between ethnic groups. Management and treatment The aim of treatment dermatomiossitis to reduce long-term morbidity and to restore physical function.
Juvenile dermatomyositis – Wikipedia
Webarchive template wayback links Articles lacking in-text citations from April All articles lacking in-text citations Infobox medical condition new. In the cases where dermatomiostis or second-line drugs are not tolerated or are ineffective, there are other treatments that can be tried.
Muscle disorders in childhood, 2. Arthritis Rheum, 30pp. Other useful criteria include myositis-specific or -related antibodies, nailfold capillaroscopy, factor VIII-related antigen, muscle ultrasound, calcinosis and neopterin.
You can change the settings or obtain more information by clicking here.
Other signs may include falling, dysphoniaor dysphagia. Methotrexate may also be used, and for severe disease, intravenous methylprednisolone IVMP. Some patients develop contracturesdeermatomiositis the muscle shortens and causes joints to stay bent; exercise, occupational therapy, and physical therapy can prevent this.
J Rheumatol, 23pp.
April Learn how and when to remove this template message. Study of antibody to organ-specific juveniil nuclear antigens. Raynaud’s phenomenon and inflammatory arthritis.
The muscle weakness often causes a dermatokiositis misdiagnosis of muscular dystrophy or other muscle disease. Cutaneouschanges of dermatomyositis precede muscle weakness. J Rheumatol, 13pp.
Pediatrics Systemic connective tissue disorders. Continuing navigation will be considered as acceptance of this use. MR findings in this disease may be useful in establishing its diagnosis within the clinical context.